Health Care Industry Spends $30B A Year Pushing Its Wares, From Drugs To Stem Cell Treatment
Critics say patients are often misled by ads that advocate high-priced drugs or genetic tests.
Drugs
861 - 880 of 1,299 Results
-
-
Will I Always Face The Threat Of A Peanut-Laden Kiss Of Death?
A reporter with a serious peanut allergy explains what it is like to process news reports that tout new pharmaceutical products that might minimize the danger of accidental exposure.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you dont have to.
-
Tainted Drugs
When Medicine Makes Patients Sicker
The Food and Drug Administration is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a KHN review of thousands of FDA documents inspection records, recalls, warning letters and lawsuits reveals how drugs that are poorly manufactured or contaminated can reach consumers.
-
Medicaid Patients In Puerto Rico Dont Get Coverage For Drugs To Cure Hepatitis C
The program that provides health care for about half of the U.S. territorys population cannot afford to cover the drugs.
-
Podcast: KHNs What The Health? Ask Us Anything!
From Medicare dental coverage to drug prices to fetal tissue research, the panelists answer listeners questions. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHNs Julie Rovner.
-
How Sen. Orrin Hatch Changed America’s Health Care
Utah's Orrin Hatch is leaving the Senate, after 42 years. The Republican led bipartisan efforts to provide health care to more kids and AIDS patients. He also thrived on donations from the drug industry.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you dont have to.
-
Podcast: KHNs What The Health? More On That Texas Lawsuit, And The Best And Worst Health Policy Stories Of The Year
The fallout continues from that Texas court decision that ruled Congress 2017 elimination of the tax penalty for failing to have insurance rendered the entire Affordable Care Act unconstitutional. Meanwhile, enrollment for 2019 at healthcare.gov was down, but far less than many predicted. KHNs Julie Rovner, along with panelists Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of the Washington Examiner, discuss this, plus the best, most overhyped and nerdiest stories of 2018. Also, Rovner interviews GOP strategist and pollster Frank Luntz.
-
Why The U.S. Remains The World’s Most Expensive Market For Biologic Drugs
Biologic drugs, made from living organisms, are big moneymakers partly because they have little competition from biosimilars. Its a very different story in Europe.
-
Health Care Industry Pays Tribute To Californias Influential Lawmakers
The leaders of Californias legislative health committees who wield power over state health policy have been showered with money from the health care sector, with drug companies, health plans, hospitals and doctors providing nearly 40 percent of their 2017-18 campaign funds.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you dont have to.
-
Nurse Denied Life Insurance Because She Carries Naloxone
The U.S. surgeon general has called on "bystanders" to be equipped with the opioid reversal drug to save lives. But when a nurse answered that call, her application for life insurance was denied. Why?
-
For The Asking, A Check Is In The Mail To Help Pay For Costly Drugs
Its a little-known secret that patients can get thousands of dollars directly from a drugmaker.
-
‘We’re Fighting For Our Lives’: Patients Protest Sky-High Insulin Prices
The price of insulin keeps going up. For people with Type 1 diabetes, high prices can be a life-or-death issue. Now a grass-roots movement is pushing for change.
-
No Cash, No Heart. Transplant Centers Require Proof Of Payment.
The case of a Michigan woman told to fundraise $10,000 for a heart transplant sparked viral outrage, but experts say wallet biopsies are common.
-
Readers And Tweeters Demand Action On Gun Violence, Mental Health Care Options
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Government Investigation Finds Flaws In the FDAs Orphan Drug Program
A probe by the Government Accountability Office cites breakdowns in the Food and Drug Administration program that approves drugs for rare diseases.
By Sarah Jane Tribble and Sydney Lupkin -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you dont have to.
-
Podcast: KHNs What The Health? Reading The Tea Leaves In Blue Waves Wake
In this episode of KHNs What the Health? Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Alice Ollstein of Politico and Anna Edney of Bloomberg News discuss the impact of House Democratic leadership elections and their impact on health policy; as well as efforts by the Trump administration to address high drug prices and ensure the safety of medical devices. Plus, Julie Rovner interviews KHNs Jay Hancock about the latest Bill of the Month.